Inhibition of human cloned BCATm expressed in Escherichia coli BL21 DE3 assessed as L-glutamate production from alpha-ketoglutarate after 10 mins by fluorescent assay
Inhibition of BCATm in C57Black/6J mouse assessed as increase of leucine level in serum at 10 to 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in C57Black/6J mouse assessed as increase of isoleucine level in serum at 10 to 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in C57Black/6J mouse assessed as increase of valine level in serum at 10 to 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in C57Black/6J mouse assessed as increase of serine level in serum at 10 to 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in C57Black/6J mouse assessed as increase of tyrosine level in serum at 10 to 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in po dosed C57Black/6J mouse assessed as increase of leucine level in serum administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in po dosed C57Black/6J mouse assessed as increase of isoleucine level in serum administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in po dosed C57Black/6J mouse assessed as increase of valine level in serum administered 5 hrs before amino acid meal by HPLC analysis
Inhibition of BCATm in C57Black/6J mouse assessed as increase of leucine level in serum at 100 mg/kg, po administered 5 hrs before amino acid meal by HPLC analysis (Rvb = 473 uM)